Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethylene Glycol | HCID 174 | — |
| Reactant | Triethylamine | HCID 8471 | — |
| Reactant | Triphosgene | HCID 94429 | — |
| Reactant | HCID 66589022 | HCID 66589022 | — |
| Solvent | Tetrahydrofuran | HCID 8028 | — |
| Product | HCID 91370646 | HCID 91370646 | 56% |
Reaction Steps
A solution of 4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)-1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-6-yl)aniline (85 mg, 0.17 mmol) in tetrahydrofuran (6 mL) was treated with triphosgene (26 mg, 0.09 mmol), followed by triethylamine (0.11 mL). After the passage of five minutes, ethylene glycol (0.14 mL) was added. The mixture was concentrated to dryness under reduced pressure. The resultant residue was purified via reverse-phase high performance liquid chromatography using a Phenomenex Gemini 21 mm×100 mm column, running a gradient elution of 10% acetonitrile/90% of 0.1% aqueous trifluoroacetic acid to 70% acetonitrile over 20 minutes. After the concentration of fractions under reduced pressure, 2-hydroxyethyl(4-{4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]-1H-pyrazolo[3,4-d]pyrimidin-6-yl}phenyl)carbamate (55 mg, 56%) was obtained as clear blond semi-solid. MS (ES+): 576.1, 577.1 (M+H)+
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08129371B2 |
|---|
| Source dataset | uspto-grants-2012_03 |
|---|
| ORD ID | ord-4dfb12530ca54b8e881b994144bb7a19 |
|---|
| Source note | uspto-grants-2012_03 |
|---|